▎ fɔ Ovagen Risach
Wetin na di risach bakgrɔn fɔ Vesilute?
insay di εksplכreshכn fכ bayoaktiv sכbstans dεm, pεptida dεn dכn gεt sכm atεnshכn biכs fכ dεn pivotal rol dεm insay plεnti fysiolojikal prכsεs dεm. Vesilute, we na sεntetik bayoaktiv pεptida we de insay di Havensone pεptida famili, de fכm wan kכr amino asid sikεns fכ Glu-Asp. Di fɔs risach we dɛn bin du pan Vesilute bin rili smɔl. כltu, we dεn gi in strכkchכral similitu wit Prostamax — wan כda Glu-Asp sikεns-kכntεn pεptida insay di sem famili—sayntis dεm bin hypothεsis se i kin posεs analכg tisu-mכdulet fכnshכn dεm, we de initiate wan joyn fכ in-dip invεstigeshכn.
Urinary system disorder, lɛk krɛse sik ɛn benign prostatic hyperplasia, kin rili ambɔg di kwaliti fɔ layf, mɔ pan di ol pipul dɛm. Dɛn bin kam fɔ no se vesilute de du yunik rɛgyulatɔri ifɛkt pan blad ɛn prɔstat tisu dɛn. di risεch we dεn du afta dat sכmtεm sho se i kin infכlכw krεse stεrili inflameshn na di prכstat tisu bay we i de afekt jin εksprεshכn na di sεlyul lεvεl. i de mכdulet di kכl inflammatory indikεtכ dεm lεk di tisu swεlin, kכnjεshכn, εn sεl infiltεshכn, we de gi wan nyu we fכ adrεs di urological chalenj dεm.
Wetin na di aplikeshɔn stɔdi dɛn fɔ Vesilute?
Targeted Rɛgyuleshɔn Risach fɔ Urinary System Diseses
as bayoaktiv rεgεdyushכn pεptida insay di Havensone famili, Vesilute de hכl sεntri posishכn insay urinary sistεm sik risεch. in stכdi dεm de fכkus pan εj-rεlatεd kכndishכn dεm lεk krכnik sistayt εn benign prostatic hyperplasia (BPH), fכ impruv di prכstat maykroskyuleshכn εn inhibit abnכmal sεl proliferashכn. i de ridyus di prכstat tisu dεm we de swεla εn kכnjεshכn, i de dכn di inflammatory sεl infiltration, εn i de mek di urinary dysfunction simptom dεm lεk fכ pis bכku tεm εn fכ du kwik kwik wan. dis כgan-spεsifi k rεgεdyushכn ifekt kin riliyt to epijεnik kכntrכl εn kromozom dεnsiti כltεrayshכn dεm—wan shered sεlyul mεkanism bitwin Havensone pεpti dεm—we de fεsilitεt nכn-fכmasyutik intavεnshכn fכ dijεnεraytiv urכlכjik sik dεm.
Ekspεnd εksplכreshכn in Fεtiliti εn Smol Mכsul Fכnshכn
vεsilut de sho di kכros-tisu fysiolojikal rεgεdyushכn pכtεnshal. insay riprodaktiv hεlth, Rכshian stכdi dεm sho se i de εnhans sεl prodakshכn, mכtiliti, εn nכmal mכfכlכji rεshכn, impruv fεtiliti pכtεnshal bay we i de optimiz di jεm sεl maykro envayroment. in anti-aggregatory ifekt dεm pan blad smol mכsul de sho sכmtεm, we kin infכlכ di smol mכsul kכntraktiliti bay we i de rεgεl glycogen mεtabolism-rεlatεd εnzym aktiviti—we de gi nyu insayt dεm fכ di mכlikul mεkanism dεm fכ blad dysmotility.
Dɔn
as bayoaktiv rεgεdyushכn pεptida insay di Havensone famili, Vesilute de sho mכltifasεt aplikεshכn risεch wit klia valyu. na di kor aplikεshכn lεvεl, i de sho aw i de wok fayn fayn wan fכ intavεn di urinary sistεm dizכrd dεm. bay we i de rεgεl di prכstat maykroskyuleshכn εn sכpres di inflammatory rεspכns dεm, i de εliviet di tisu swel, kכnjεshכn, εn urinary dysfunction we kכz fכ krכnik sistayt εn benign prostatic hyperplasia, we de gi wan pכtεnshal nכn-fכmasiutik intavεnshכn aprכch fכ di ej-rεlatεd dijεnεraytiv urinary sik dεm we de fכ ol pipul dεm. insay riprodaktiv hεlth, i de optimize di sεl dεm we de fכm, di mכtiliti, εn di mכfכlכji rεshכ, we de gi nyu rod fכ fεtiliti εnhansmεnt risεch. di rεgεdyushכn ifekt dεm we i de du pan di blad smol mכsul fכnshכn de gi insayt dεm bak fכ di blad dysmotility mεkanism dεm.
bay we i de adrεs di nid dεm we dεn nכ mit insay yurכlכji εn riprodaktiv hεlth, Vesilute de fulכp di gap dεm na di sik intavεnshכn, lay fawndeshכn fכ divεlכp sef, tכgεt rεgεdyushכn sכlushכn dεm. i de enrich כndastandin fכ di bayolojikal rεgεdyushכn mεkanism dεm insay di Havensone pεptida famili, advans risεch dip in כgan-spεsifi k rεguleshכn εn kכros-sistεm fysiolojikal kכntrכl fכ pεptida sכbstans dεm. dis de gi krεs tiori εn εkspεriεns fכwndeshכn fכ sכbsεkshכn pεptida bayofamasiutik divεlכpmεnt, we de ple wan siknifikant rol.
Bɔt di pɔsin we rayt di buk
Di tin dɛn we wi dɔn tɔk bɔt, na ɔl di tin dɛn we Cocer Peptides dɔn du risach, ɛdit ɛn kɔmpilayt.
ƆL DI ATIKUL ƐN PRODƆKT INFƆMƐSHƆN WE DƐN GI NA DIS WƐBSAYT NA FƆ ƆL FƆ DI INFƆMƐSHƆN ƐN FƆ EDYUKESHƆN.
Di prɔdak dɛn we dɛn gi na dis wɛbsayt na fɔ in vitro risach nɔmɔ. in vitro risach (Latin: *in glas*, we min insay glas) dεn de du am ausayd mכtalman bכdi. Dɛn prɔdak ya nɔto famasitik, dɛn nɔ gɛt di aprɔval frɔm di US Food and Drug Administration (FDA), ɛn dɛn nɔ fɔ yuz dɛn fɔ protɛkt, trit, ɔ mɛn ɛni mɛrɛsin, sik, ɔ sik. Di lɔ nɔ gri fɔ mek dɛn put dɛn tin ya insay mɔtalman ɔ animal bɔdi ɛni we.
